医薬品グレード炭酸リチウム市場- 世界の産業規模、シェア、動向、市場機会、予測、純度別（99%、99%以上）、用途別（徐放、即時放出）、地域別、競合別、2020～2030年

医薬品グレード炭酸リチウムの世界市場は、2024年には1億4,589万米ドルとなり、2030年には1億5,297万米ドルに達すると予測され、予測期間中の年間平均成長率（CAGR）は3.75%で成長すると予測されています。

医薬品グレードの炭酸リチウム市場は、主にリチウムベースの医薬品や治療薬に対する需要の増加により、近年著しい成長を遂げています。リチウム塩である炭酸リチウムは、気分障害、特に双極性障害やうつ病の治療に使用される医薬製剤の製造において重要な役割を果たしています。

この市場成長は、メンタルヘルスに対する意識の高まり、高齢者人口の増加、神経科学におけるリチウムの応用に関する研究の進行など、いくつかの要因によるものです。2024年6月現在、国連は、世界の温室効果ガス排出量の約82%を占める107カ国がネットゼロを約束したと報告しています。このコミットメントが先進的なエネルギー貯蔵システムの需要を刺激し、炭酸リチウム市場の成長を加速させています。医薬品グレードの炭酸リチウム市場の着実な成長は、医薬品セクターの拡大と、気分障害に対するリチウムベースの治療に対する認識の高まりを反映しています。

気分障害の有病率の上昇、研究開発活動の発展、医薬製剤における炭酸リチウムの採用増加など、いくつかの主な促進要因がこの成長に寄与しています。市場拡大の重要な要因は、メンタルヘルス問題に対する意識の高まりです。メンタルヘルスに関する議論が高まり、これらの課題に取り組むことを目的とした取り組みが行われるようになったことで、診断を受ける人が増え、炭酸リチウムを含む効果的な医薬品に対する需要が高まっています。

さらに、世界人口の高齢化も、気分障害が高齢者に多いことから、炭酸リチウムのような医薬品に対する需要の増加に寄与しています。神経科学と精神医学におけるリチウムの潜在的用途に関する継続的な調査が、市場の成長をさらに後押ししています。世界保健機関（WHO）の2022年6月の報告書によると、世界では8人に1人が思考、感情調節、行動を乱す精神障害を経験しています。

主な市場促進要因

メンタルヘルスに対する意識の高まり

主な市場課題

副作用と安全性への懸念

主要市場動向

神経保護用途

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の医薬品グレード炭酸リチウム市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 純度別（99%、99%以上）
  • 用途別（徐放、即時放出）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の医薬品グレード炭酸リチウム市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の医薬品グレード炭酸リチウム市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の医薬品グレード炭酸リチウム市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の医薬品グレード炭酸リチウム市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの医薬品グレード炭酸リチウム市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（ある場合）
• 製品の発売（ある場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Arcadium Lithium PLC
• Albemarle Corporation
• Jiangsu Lianhuan Pharmaceutical Co., Ltd.
• American Elements
• Jiangsu Nhwa Pharmaceutical Co., Ltd.
• Panchsheel Organics Ltd（POLTD）
• Blanver

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Pharmaceutical Grade Lithium Carbonate Market was valued at USD 145.89 million in 2024 and is projected to reach USD 152.97 million by 2030, growing at a compound annual growth rate (CAGR) of 3.75% during the forecast period. The market for pharmaceutical-grade lithium carbonate has seen significant growth in recent years, primarily driven by the increasing demand for lithium-based medications and therapies. Lithium carbonate, a lithium salt, plays a critical role in the production of pharmaceutical formulations used to treat mood disorders, particularly bipolar disorder and depression.

This market growth is attributed to several factors, including rising mental health awareness, the expanding elderly population, and ongoing research into lithium's applications in neuroscience. As of June 2024, the United Nations reported that 107 countries, accounting for approximately 82% of global greenhouse gas emissions, have committed to net-zero pledges. This commitment is stimulating demand for advanced energy storage systems, which in turn is accelerating the growth of the lithium carbonate market. The steady growth of the pharmaceutical-grade lithium carbonate market reflects the expansion of the pharmaceutical sector and the increasing recognition of lithium-based treatments for mood disorders.

Several key drivers are contributing to this growth, such as the rising prevalence of mood disorders, growing research and development activities, and the increasing adoption of lithium carbonate in pharmaceutical formulations. A significant factor in this market's expansion is the growing awareness of mental health issues. With increasing discussions around mental health and initiatives aimed at tackling these challenges, more people are being diagnosed, which is driving demand for effective medications, including lithium carbonate.

Additionally, the aging global population is contributing to increased demand for pharmaceuticals like lithium carbonate, as mood disorders are more common among older individuals. Ongoing research into lithium's potential applications in neuroscience and psychiatric medicine further supports the market's growth. According to a June 2022 report by the World Health Organization, one in eight people globally experiences a mental disorder that disrupts thinking, emotional regulation, or behavior.

Key Market Drivers

Rising Mental Health Awareness

The pharmaceutical-grade lithium carbonate market is experiencing notable growth, largely driven by the increasing awareness of mental health issues. Lithium carbonate, primarily used to manage bipolar disorder, has gained attention as mental health awareness spreads and more individuals seek treatment for mood disorders. The increased recognition and the subsequent demand for lithium carbonate are crucial drivers of market expansion.

In recent years, there has been a significant shift in societal attitudes toward mental health, with greater emphasis on openly addressing and effectively managing mental health challenges. Advocacy campaigns, educational initiatives, and personal stories have contributed to reducing the stigma surrounding mental health conditions, encouraging individuals to seek help. As a result, more people are being diagnosed with mood disorders, depression, and bipolar disorder, further boosting demand for pharmaceutical treatments like lithium carbonate.

In May 2023, Livent announced a merger agreement with Allkem, a specialty lithium chemicals company, to form NewCo, a leading global producer of lithium chemicals. This merger will provide a diversified portfolio of low-cost assets across key geographies, product segments, and customer bases, with the deal expected to be finalized by the end of 2023.

Key Market Challenges

Side Effects and Safety Concerns

Safety concerns and potential side effects pose significant challenges to the global pharmaceutical-grade lithium carbonate market. While lithium carbonate offers substantial therapeutic benefits, particularly in the treatment of bipolar disorder and other mental health conditions, it is not without its challenges. Potential side effects can include gastrointestinal discomfort, tremors, and in some rare cases, kidney problems or thyroid dysfunction.

These side effects, along with the need for careful monitoring, require healthcare providers and patients to approach lithium treatment with caution. Furthermore, regulatory agencies around the world have implemented stringent monitoring and reporting requirements, adding complexity and cost to its pharmaceutical use. To address these challenges, the pharmaceutical-grade lithium carbonate market must focus on research and development to minimize side effects and enhance drug delivery systems. Additionally, educational initiatives should ensure safe and effective use, and ongoing collaboration between healthcare professionals, patients, and regulatory authorities is vital to balancing therapeutic benefits with safety.

Key Market Trends

Neuroprotective Applications

Research into the neuroprotective applications of lithium carbonate has emerged as a key trend in the global pharmaceutical-grade lithium carbonate market. Lithium carbonate, traditionally used in psychiatric treatment, is gaining attention for its potential neuroprotective properties. This trend is driven by the growing understanding of lithium's therapeutic benefits beyond its traditional role in managing mood disorders.

Researchers and pharmaceutical companies are increasingly exploring lithium carbonate's potential to protect neurons and potentially slow the progression of neurodegenerative diseases like Alzheimer's and Parkinson's disease. Studies suggest that lithium may influence various neuroprotective mechanisms, including reducing inflammation, promoting neurogenesis, and modulating neurotransmitter levels. As a result, there has been an increase in research and development investments aimed at creating lithium carbonate formulations specifically designed for neuroprotection.

With the global population aging and the incidence of neurodegenerative diseases rising, the demand for effective treatments and interventions continues to grow. The exploration of lithium carbonate's neuroprotective applications presents a promising opportunity for both pharmaceutical companies and patients seeking innovative therapies for neurological disorders. While further research is needed to fully understand its potential, the focus on neuroprotective properties highlights the dynamic nature of the pharmaceutical-grade lithium carbonate market and its potential to revolutionize the treatment of neurodegenerative diseases in the future.

Key Market Players

• Arcadium Lithium PLC
• Albemarle Corporation
• Jiangsu Lianhuan Pharmaceutical Co., Ltd.
• American Elements
• Jiangsu Nhwa Pharmaceutical Co., Ltd.
• Panchsheel Organics Ltd (POLTD)
• Blanver

Report Scope

This report segments the Global Pharmaceutical Grade Lithium Carbonate Market into the following categories, along with an analysis of the key industry trends:

By Purity:

• 99%
• Above 99%

By Application:

• Extended Release
• Immediate Release

By Region:

• North America (United States, Canada, Mexico)
• Europe (France, United Kingdom, Italy, Germany, Spain)
• Asia-Pacific (China, India, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

This section provides a detailed analysis of the major companies operating in the global pharmaceutical-grade lithium carbonate market.

Available Customizations

TechSci Research offers customized solutions for the global pharmaceutical-grade lithium carbonate market report to meet specific business needs.

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Grade Lithium Carbonate Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Purity (99%, Above 99%)
  • 5.2.2. By Application (Extended Release, Immediate Release)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Pharmaceutical Grade Lithium Carbonate Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Purity
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Purity
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Purity
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Purity
      • 6.3.3.2.2. By Application

7. Europe Pharmaceutical Grade Lithium Carbonate Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Purity
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Purity
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Purity
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Purity
      • 7.3.3.2.2. By Application
  • 7.3.4. France Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Purity
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Purity
      • 7.3.5.2.2. By Application

8. Asia-Pacific Pharmaceutical Grade Lithium Carbonate Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Purity
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Purity
      • 8.3.1.2.2. By Application
  • 8.3.2. India Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Purity
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Purity
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Purity
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Purity
      • 8.3.5.2.2. By Application

9. South America Pharmaceutical Grade Lithium Carbonate Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Purity
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Purity
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Purity
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Purity
      • 9.3.3.2.2. By Application

10. Middle East and Africa Pharmaceutical Grade Lithium Carbonate Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Purity
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Purity
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Purity
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Pharmaceutical Grade Lithium Carbonate Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Purity
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Arcadium Lithium PLC
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Albemarle Corporation
• 14.3. Jiangsu Lianhuan Pharmaceutical Co., Ltd.
• 14.4. American Elements
• 14.5. Jiangsu Nhwa Pharmaceutical Co., Ltd.
• 14.6. Panchsheel Organics Ltd (POLTD)
• 14.7. Blanver

15. Strategic Recommendations

16. About Us & Disclaimer